Richter granted Stada non-exclusive rights to distribute its biosimilar of rituximab in Europe and the Commonwealth of Independent States (CIS) excluding Russia

Gedeon Richter plc

Hungary / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Stada Arzneimittel AG

Germany / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced